Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Akira Seza"'
Autor:
Makoto Taoka, Akira Sezai, Masanao Ohba, Yoshiki Kitazumi, Taisuke Hanamura, Yasuo Okumura, Masashi Tanaka
Publikováno v:
Clinical Case Reports, Vol 12, Iss 5, Pp n/a-n/a (2024)
Key Clinical Message A woman with a single coronary artery underwent aortic valve replacement due to aortic stenosis. Two years later, she developed an aortic annular abscess around the right coronary cusp and non‐coronary cusp. Significant adhesio
Externí odkaz:
https://doaj.org/article/c6f9f45c561249c2b6a4fb1d63a74454
Autor:
Atsushi Tanaka, Takumi Imai, Michio Shimabukuro, Isao Taguchi, Akira Sezai, Shigeru Toyoda, Hirotaka Watada, Junya Ako, Koichi Node, the CANDLE trial investigators
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-11 (2022)
Abstract Background Insulin resistance and hyperinsulinemia in patients with type 2 diabetes (T2D) are adversely associated with the development and worsening of heart failure (HF). Herein, we sought to investigate the effect of canagliflozin on insu
Externí odkaz:
https://doaj.org/article/b4bf2f310b7841f79e5edc62b978251f
Autor:
Atsushi Hirayama, Satoshi Ozaki, Ayako Tano, Nobuyuki Fujii, Yosihiro Aizawa, Yuji Kasamaki, Satoshi Kunimoto, Toshiko Nakai, Masakatsu Ohta, Motomi Shiono, Hiroaki Mano, Akira Seza, Ichiro Watanabe, Tatsuya Kofune
Publikováno v:
Journal of Nihon University Medical Association. 69:304-309
Publikováno v:
Biomedicines, Vol 11, Iss 3, p 946 (2023)
Erythropoiesis-stimulating agents improve the NYHA functional class and decrease the hospital readmission rates for heart failure; however, little is known about the influence of continuous erythropoietin receptor activator (CERA) on the heart. There
Externí odkaz:
https://doaj.org/article/94cd83a8ebc04d28b72fcde2d4469667
Autor:
Yuki Saito, Naoki Matsumoto, Yoshihiro Aizawa, Daisuke Fukamachi, Daisuke Kitano, Toyama Kazuto, Takehiro Tamaki, Hidesato Fujito, Akira Sezai, Yasuo Okumura
Publikováno v:
ESC Heart Failure, Vol 7, Iss 6, Pp 4005-4014 (2020)
Abstract Aims Congestive splenomegaly is a classic sign of organ congestion in acute decompensated heart failure (ADHF). Shear wave elastography (SWE) allows the measurement of spleen stiffness (SS). We hypothesized that SS could quantify the severit
Externí odkaz:
https://doaj.org/article/746383e0ddb44b71ab363879cdb62abc
Autor:
Atsushi Tanaka, Itaru Hisauchi, Isao Taguchi, Akira Sezai, Shigeru Toyoda, Hirofumi Tomiyama, Masataka Sata, Shinichiro Ueda, Jun‐ichi Oyama, Masafumi Kitakaze, Toyoaki Murohara, Koichi Node, CANDLE Trial Investigators
Publikováno v:
ESC Heart Failure, Vol 7, Iss 4, Pp 1585-1594 (2020)
Abstract Aims Little is known about the impact of sodium glucose co‐transporter 2 (SGLT2) inhibitors on cardiac biomarkers, such as natriuretic peptides, in type 2 diabetes (T2D) patients with concomitant chronic heart failure (CHF). We compared th
Externí odkaz:
https://doaj.org/article/04db0cf384aa4091bf15508921787e21
Autor:
Ran Tamiya, Yuki Saito, Daisuke Fukamachi, Koichi Nagashima, Yoshihiro Aizawa, Kimie Ohkubo, Takumi Hatta, Akira Sezai, Masashi Tanaka, Taisuke Ishikawa, Naomasa Makita, Naokata Sumitomo, Yasuo Okumura
Publikováno v:
ESC Heart Failure, Vol 7, Iss 3, Pp 1338-1343 (2020)
Abstract Desmin‐related myopathy (DRM) is a rare heritable cardiac and skeletal muscle disease caused by mutations in the desmin gene (DES). DRM is generally characterized by skeletal muscle weakness, conduction disturbance, and dilated cardiomyopa
Externí odkaz:
https://doaj.org/article/38d8bb99c15e4442981682f4942f54e1
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-13 (2019)
Abstract Background Reports that sodium glucose cotransporter 2 inhibitors decrease cardiovascular death and events in patients with diabetes have attracted attention in the cardiology field. We conducted a study of canagliflozin in patients with chr
Externí odkaz:
https://doaj.org/article/64f81cd7ab1b4712a4ea4fc8b6bc5420
Autor:
Akira Sezai, Atsushi Tanaka, Takumi Imai, Keisuke Kida, Hisakuni Sekino, Toyoaki Murohara, Masataka Sata, Norio Suzuki, Koichi Node
Publikováno v:
Biomedicines, Vol 10, Iss 7, p 1656 (2022)
Background: We present results of a 24-week comparative study of the effects of the sodium–glucose cotransporter 2 (SGLT2) inhibitor canagliflozin vs. the sulfonylurea glimepiride, by baseline body mass index (BMI), in patients with type 2 diabetes
Externí odkaz:
https://doaj.org/article/03559250ece442bbb78dafa13053bc9d
Autor:
Atsushi Tanaka, Isao Taguchi, Hiroki Teragawa, Nobukazu Ishizaka, Yumiko Kanzaki, Hirofumi Tomiyama, Masataka Sata, Akira Sezai, Kazuo Eguchi, Toru Kato, Shigeru Toyoda, Ryoichi Ishibashi, Kazuomi Kario, Tomoko Ishizu, Shinichiro Ueda, Koji Maemura, Yukihito Higashi, Hirotsugu Yamada, Mitsuru Ohishi, Kotaro Yokote, Toyoaki Murohara, Jun-Ichi Oyama, Koichi Node, PRIZE study investigators
Publikováno v:
PLoS Medicine, Vol 17, Iss 4, p e1003095 (2020)
BackgroundAn elevated level of serum uric acid (SUA) is associated with an increased risk of cardiovascular disease. Pharmacological intervention with urate-lowering agents, such as the conventional purine analogue xanthine oxidase (XO) inhibitor, al
Externí odkaz:
https://doaj.org/article/f72a09fd60fc40b889b59a7f8f3ef9f8